Development and validation of a radiomics signature on differentially expressed features of 18F-FDG PET to predict treatment response of concurrent chemoradiotherapy in thoracic esophagus squamous cell carcinoma.
CONCLUSION: This study indicated that the proposed radiomics signature could be a useful image marker to predict the therapeutic response of thoracic ESCC patients treated with CCRT.
PMID: 32065875 [PubMed - as supplied by publisher]
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - Category: Radiology Authors: Cao Q, Li Y, Li Z, An D, Li B, Lin Q Tags: Radiother Oncol Source Type: research
More News: Cancer & Oncology | Carcinoma | Esophagus Cancer | Radiology | Skin Cancer | Squamous Cell Carcinoma | Study | Training | Universities & Medical Training